极低龄单侧聋儿童的人工耳蜗植入
本研究回顾性分析了2014至2022年间19例5岁及以下单侧聋儿童接受人工耳蜗植入的经历,中位植入年龄2.8岁(范围1.0-5.4岁),其中15例(79%)植入时不足5岁。术后无并发症,12例实现持续使用(平均9小时/天),3例有术前术后言语测试者显示显著获益,5例术后测试者植入耳在隔绝好耳时表现出言语识别。结论认为人工耳蜗可安全用于低龄单侧聋儿童,适应人群可扩展至5岁以下。
要点
- 19例5岁及以下单侧聋患儿植入人工耳蜗,中位年龄2.8岁,无术后并发症。
- 12例实现持续使用(平均9小时/天),3例未持续使用者伴耳蜗神经发育不良和/或发育迟缓。
- 有测试数据的患儿显示言语识别获益,作者认为适应人群可扩展至5岁以下。
核心结论
- 人工耳蜗可安全用于低龄单侧聋儿童,患者及家庭接受早期植入并以持续使用为证,言语识别获得显著获益。
- 作者认为适应人群可扩展至5岁以下单侧聋患者,尤其是不伴耳蜗神经发育不良或发育迟缓者。
研究设计与样本
- 研究设计为带病历回顾的病例系列。
- 研究机构为三级转诊中心。
- 研究纳入2014年至2022年间接受人工耳蜗植入的19例5岁及以下单侧聋患者。
- 收集基线特征、围手术期并发症、设备使用情况及言语结果。
主要发现
- 植入时中位年龄为2.8岁(范围1.0-5.4岁),其中15例(79%)植入时不足5岁。
- 听力损失病因包括特发性(n=8)、巨细胞病毒(n=4)、前庭水管扩大(n=3)、耳蜗神经发育不良(n=3)及脑膜炎(n=1)。
- 术前纯音平均值在差耳为90 dB eHL(范围75-120),在较好耳为20 dB eHL(范围5-35)。
- 无患者出现术后并发症。
- 12例患者实现持续设备使用(平均9小时/天);7例未持续使用者中3例伴耳蜗神经发育不良和/或发育迟缓。
临床怎么用
- 作者认为人工耳蜗可安全用于低龄单侧聋儿童。
- 作者认为适应人群可扩展至5岁以下单侧聋患者,尤其是不伴耳蜗神经发育不良或发育迟缓者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cochlear implants (CIs) for single-sided deafness (SSD) have only been approved for patients 5 years and older despite data supporting that younger children can also benefit from implantation. This study describes our institution's experience with CI for SSD in children 5 years and younger. STUDY DESIGN: Case series with chart review. SETTING: Tertiary referral center. METHODS: A case series with chart review identified 19 patients up to age 5 years who underwent CI for SSD between 2014 and 2022. Baseline characteristics, perioperative complications, device usage, and speech outcomes were collected. RESULTS: The median age at CI was 2.8 (range, 1.0-5.4) years, with 15 (79%) patients being below age 5 at implantation. Etiologies of hearing loss were idiopathic (n = 8), cytomegalovirus (n = 4), enlarged vestibular aqueduct (n = 3), hypoplastic cochlear nerve (n = 3), and meningitis (n = 1). The median preoperative pure-tone average was 90 (range, 75-120) and 20 (range, 5-35) dB eHL in the poor and better hearing ears, respectively. No patients had postoperative complications. Twelve patients achieved consistent device use (average, 9 h/d). Three of the seven who were not consistent users had hypoplastic cochlear nerves and/or developmental delays. The three patients with available preoperative and postoperative speech testing showed significant benefits, and five patients with available postoperative testing demonstrated speech recognition in the implanted ear when isolated from the better ear. CONCLUSION: CI can safely be performed in younger children with SSD. Patients and families accept early implantation, as evidenced by consistent device use, and derive notable benefits in speech recognition. Candidacy can be broadened to include SSD patients under age five years, particularly individuals without hypoplastic cochlear nerves or developmental delay.
引用
- Patro A, Holder JT, Brown CL, et al. Cochlear Implantation in Very Young Children With Single-Sided Deafness. Otolaryngol Head Neck Surg. 2023. PMID: 37232481. doi:10.1002/ohn.375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。